Paolo Carlini
Yahoo!
145 Papers
1.5K Citations
Paolo Carlini is an academic researcher from Yahoo!. The author has contributed to research in topics: Breast cancer & Medicine. The author has an hindex of 32, co-authored 141 publications.
Chat about Author
Papers
Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma
Vittorio Franciosi,Giorgio Cocconi,Maria Michiara,Francesco Di Costanzo,Vinicio Fosser,Maurizio Tonato,Paolo Carlini,Corrado Boni,Sofia Di Sarra +8 more
TL;DR: In this paper, the authors reported that the combination of cisplatin (P) and etoposide (E) had strikingly high activity in patients with brain metastases from breast carcinoma.
194
Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors.
Serena Di Cosimo,Gianluigi Ferretti,Paola Papaldo,Paolo Carlini,Alessandra Fabi,Francesco Cognetti +5 more
TL;DR: The available data demonstrate a significant role of lonidamine in modulating anthracycline and platinum compound activity, and the encouraging results of phase II-III trials for the treatment of advanced breast, ovarian and lung cancer must be confirmed by larger studies.
168
Zoledronic-acid-induced circulating level modifications of angiogenic factors, metalloproteinases and proinflammatory cytokines in metastatic breast cancer patients.
Gianluigi Ferretti,Alessandra Fabi,Paolo Carlini,Paola Papaldo,Paola Cordiali Fei,Serena Di Cosimo,Nello Salesi,Diana Giannarelli,Andrea Alimonti,Barbara Di Cocco,Giovanna D'Agosto,Valentina Bordignon,Elisabetta Trento,Francesco Cognetti +13 more
TL;DR: ZA could exert an antiangiogenic activity and inhibition of tumor cell bone invasiveness by a transient reduction of VEGF, bFGF and MMP-2 circulating levels after infusion.
140
Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer? Meta-analysis of randomized trials.
Federica Cuppone,Emilio Bria,Sunil Verma,Kathleen I. Pritchard,Sonal Gandhi,Paolo Carlini,Michelle Milella,Cecilia Nisticò,Edmondo Terzoli,Francesco Cognetti,Diana Giannarelli +10 more
TL;DR: Despite the advantages from using aromatase inhibitors compared with tamoxifen for early breast cancer, an unexpectedly greater number of grade 3 and 4 cardiovascular events (CVAE) was demonstrated.
126
Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC).
F. Di Costanzo,Paolo Carlini,L. Doni,Bruno Massidda,Rodolfo Mattioli,A. Iop,E Barletta,Luca Moscetti,F Recchia,Paolo Tralongo,Silvia Gasperoni +10 more
TL;DR: This study does not show promising activity in terms of RR, PFS and OS for the double combination arm in APC.